SEARCH

SEARCH BY CITATION

References

  • 1
    Merchant DJ. Estrogen-replacement therapy after breast cancer. Cancer 1993; 71: 216976.
  • 2
    Edman CD. The climacteric. In: BuchsbaumHJ, editor. The menopause. New York: Springer Verlag, 1983: 2333.
  • 3
    Marchant DJ, Sutton FM. Use of mammography: United States 1990. MMWR Morb Mortal Wkly Rep 1990; 39: 6219.
  • 4
    Horton JA, Romans MC, Cruess DF. Mammography, attitudes, and usage study. Womens Health Issues 1992; 2: 1808.
  • 5
    Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women. N Engl J Med 1993; 329: 24756.
  • 6
    Matthews KA, Meilahn E, Kuller LH, Caggiula AW, Kelsey SF, Wing RR, et al. Menopause and risk factors for coronary heart disease. N Engl J Med 1989; 321: 6416.
  • 7
    Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH, et al. Menopause and the risk of coronary disease in women. N Engl J Med 1987; 316: 110510.
  • 8
    ishell DR, editor. Interdisciplinary review of estrogen replacement therapy. Am J Obstet Gynecol 1989; 161 (Suppl): 182564.
  • 9
    Utian WH, editor. Current perspectives in the management of the menopause and postmenopausal patient. Obstet Gynecol 1990; 75 (Suppl): 181.
  • 10
    Gal D, Kopel S, Bashevkin M, Lebowicz J, Lev R, Taner ML, et al. Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer: preliminary report. Gynecol Oncol 1991; 42: 1203.
  • 11
    Gusberg SB. Tamoxifen for breast cancer: associated endometrial cancer [editorial]. Cancer 1990; 65: 14634.
  • 12
    Love RR, Newcomb PA, Wiebe DA, Surawicz TS, Jordan VC, Carbone PP, et al. Lipid and lipoprotein effects of tamoxifen therapy in postmenopausal patients with node negative breast cancer. J Natl Cancer Inst 1990; 82: 132732.
  • 13
    Wile AG, DiSaia PJ. Hormones and breast cancer. Am J Surg 1989; 157: 43842.
  • 14
    Creasman WT. Estrogen replacement therapy: is previously treated cancer a contraindication? Obstet Gynecol 1991; 77: 30812.
  • 15
    Korenman SG. The endocrinology of breast cancer. Cancer 1980; 46: 874.
  • 16
    Korenman SG. Estrogen window hypothesis of the etiology of breast cancer. Lancet 1980; 1: 700.
  • 17
    Martin MC, Block JE, Sanchez SD, Arnaud CD, Beyene Y. Menopause without symptoms: the endocrinology of menopause among rural Mayan Indians. Am J Obstet Gynecol 1993; 168: 183945.
  • 18
    Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiological evidence. Prev Med 1991; 20: 4763.
  • 19
    Barrett-Connor E, Bush TL. Estrogen replacement and coronary heart disease. Cardiovasc Clin 1989; 19: 15972.
  • 20
    Grady D, Rubin SM, Petitti DB. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 101637.
  • 21
    Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 1991; 325: 75662.
  • 22
    Nabulsi MB, Folson AR, White A, Patsah W, Heiss G, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993; 328: 106976.
  • 23
    Prince RL, Smith M, Dick IM, Price RI, Webb PG, Henderson NK, et al. Prevention of postmenopausal osteoporosis. N Engl J Med 1991; 325: 118995.
  • 24
    Colditz GA, Stampfer MJ, Willett WC. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA 1990; 264: 264853.
  • 25
    Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol 1993; 168: 147380.
  • 26
    Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991; 265: 198590.
  • 27
    Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991; 151: 6772.
  • 28
    Kalache A, McPherson K, Barltrop K, Vessey MP. Oral contraceptives and breast cancer. Br J Hosp Med 1983; 30 (4): 27883.
  • 29
    Wingo PA, Lee NC, Ory H, Beral V, Peterson HB, Rhodes P, et al. Age specific differences in the relationship between oral contraceptive use and breast cancer. Obstet Gynecol 1991; 78: 16170.
  • 30
    Romieu I, Berlin JA, Colditz G. Oral contraceptives and breast cancer: review and meta-analysis. Cancer 1990; 66: 225363.
  • 31
    Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytoxic, or immune therapy. Lancet 1992; 339: 115, 71–85.
  • 32
    Lobo RA. Hormone replacement therapy: estrogen replacement after treatment for breast cancer. Lancet 1993; 341: 1313.
  • 33
    Danforth DN. How subsequent pregnancy affects outcome in women with a prior breast cancer. Oncology 1991; 5: 2335.